| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 02/10/2005 | US20050033261 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/03/2005 | WO2005009971A1 Quinolone derivative or salt thereof |
| 02/03/2005 | WO2005009480A2 Implants containing codrugs |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050026990 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders |
| 02/03/2005 | US20050025794 Film-forming compositions and methods |
| 02/03/2005 | CA2530352A1 Quinolone derivative or salt thereof |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501813A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 01/27/2005 | WO2005007211A2 Medical devices with proteasome inhibitors for the treatment of restenosis |
| 01/27/2005 | DE102004027363A1 Verfahren zur Reparatur und zur Regeneration menschlicher Dura Mater A method for repair and regeneration of human dura mater |
| 01/26/2005 | EP1500664A1 Gelatin derivatives and high-molecular micelles comprising the same |
| 01/26/2005 | EP1499329A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 01/26/2005 | CN1571676A Biphasic mixtures of GLP-1 and insulin |
| 01/26/2005 | CN1569024A Novel post-operation antiadhesive materials and its preparation method |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1497330A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1496835A2 Compositions and methods for systemic inhibition of cartilage degradation |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | CA2530480A1 Conjugated complement cascade inhibitors |
| 01/12/2005 | EP1494687A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183922C Medicine for treating postoperative adhesion and its preparing process |
| 01/12/2005 | CN1183916C Use of lactic acid bacterium for the treatment of peritonitis |
| 01/12/2005 | CN1183906C Preparation process for surfaceanesthesia cream |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004037 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 01/05/2005 | EP1493745A1 New crystalline and amorphous form of a triazolo(4,5-D)pyrimidine compound |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492525A2 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 01/05/2005 | EP1492501A1 Methods of using lamellar bodies for therapeutic purposes |
| 01/05/2005 | EP1073413B1 Methods and compositions for stabilizing acetylcholine compositions |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/04/2005 | US6838078 Film-forming compositions and methods |
| 12/30/2004 | US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490479A1 Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
| 12/29/2004 | CN1557508A Adhesion preventing membrane and its preparing method |
| 12/29/2004 | CN1181894C Dextrin-containing composition for preventing surgical adhesions |
| 12/29/2004 | CN1181822C Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemia conditions |
| 12/22/2004 | CN1180841C Method to enhance healing of sternum after sternotomy |
| 12/22/2004 | CN1180826C Medicament for promoting exhaustion from anus and its preparation method |
| 12/21/2004 | CA2227241C Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 12/16/2004 | WO2004108179A1 Compositions for repairing and regenerating human dura mater |
| 12/16/2004 | US20040254107 Biphasic mixtures of glp-1 and insulin |
| 12/09/2004 | WO2004024168A8 Composition and method for use in intestinal cleansing procedures |
| 12/09/2004 | US20040247681 An acrylated polypropylene glycol or 1,2-propylene oxide adduct copolymerized with an acrylic silyl ester or an acrylic ketone; controlled release ocular inserts; glaucoma, cataracts |
| 12/08/2004 | EP1484070A1 Compositions for repairing and regenerating human dura mater |
| 12/08/2004 | EP1484061A1 Drugs containing riboflavin-type compounds |
| 12/08/2004 | EP1482975A2 Prevention of tissue adhesion |
| 12/08/2004 | EP1482962A2 Method of treating trx mediated diseases |
| 12/08/2004 | EP1341754B1 Substituted anthranilic acids |
| 12/08/2004 | CN1553951A Human cord blood derived unrestricted somatic stem cells (USSC) |
| 12/08/2004 | CN1178936C Sulfonyl-pyrrolidine derivatives |
| 12/07/2004 | US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics |
| 12/07/2004 | US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect |
| 12/02/2004 | US20040241803 25 human secreted proteins |
| 12/02/2004 | US20040241241 Crosslinked reaction product of acrylamide, N,N'-methylen-bis-acrylamide, N,N'-ethylen-bis-acrylanmide, poviargolum and water; useful as endoprosthesis replacements, dosage forms for long term pharmacotherapy, and as carriers for cultivation of cells |
| 12/01/2004 | EP1480688A1 N-(5- 4-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 12/01/2004 | EP1480658A2 Methods of treating vascular disease |
| 12/01/2004 | EP1263761B1 Compounds for pdt |
| 12/01/2004 | CN1551779A Osteogenis oligopeptide as blood-formation stimulation articles |
| 11/30/2004 | US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids |
| 11/25/2004 | US20040235786 Highly purified antiendotoxin compound |
| 11/24/2004 | CN1549732A Multifunction biological compatible aquogel and producing process thereof |
| 11/23/2004 | US6821984 Ring fused pyrazole derivatives as CRF antagonists |
| 11/18/2004 | US20040229823 For use in therapy of growth metabolic disorders |
| 11/18/2004 | US20040229804 Tribonectins |
| 11/17/2004 | EP1477182A1 Novel analgesics |
| 11/17/2004 | EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 11/17/2004 | CN1547478A Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 11/11/2004 | US20040224314 G-protein coupled receptors |
| 11/10/2004 | EP1474445A1 Glycoisoforms of adiponectin and uses thereof |
| 11/10/2004 | EP1474137A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
| 11/10/2004 | CN1543981A Anti-adhesion drug composition and its preparation and application |
| 11/04/2004 | WO2003063799A3 Compositions and methods for systemic inhibition of cartilage degradation |
| 11/04/2004 | US20040220133 Composition and method for inhibiting platelet aggregation |
| 11/04/2004 | US20040219134 implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues |
| 11/03/2004 | EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 11/03/2004 | EP1472242A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide |
| 11/03/2004 | CN1543361A Synechia inhibitory material |
| 11/02/2004 | US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists |
| 11/02/2004 | US6812220 Pharmaceutical compositions and methods relating to fucans |
| 10/28/2004 | US20040214793 In aitu applying to bone joints |
| 10/28/2004 | US20040214762 administering serine protease inhibitors and optionally in combination with substance P or peptide hormones, for prophylaxis of nervous system disorders, autoimmune disorders and tissue regeneration processes, such as wound healing |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/27/2004 | EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators |
| 10/27/2004 | CN1539515A Biomaterial for preventing accretion after surgery and preparation method |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | CA2127214C New use of beta-naphtoquinone derivatives and of their salts for the production of a medicament which accelerate the growth of endothelial cells to inhibit no synthtases |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |